Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
  1. 4 Open-market sale Chief Technology Officer sold 7,738 shares at $178.00 ($1,377,364)
  2. 4 Open-market sale Director sold 6,674 shares at an average $175.74 ($1,172,886)
  3. 4 Planned sale Director sold 826 shares at $175.00 ($144,550)
  4. 4 Planned sale Director sold 116 shares at $175.00 ($20,300)
  5. 4 Option exercise Director acquired 1,651 shares (option exercise)
  6. 4 Open-market sale Chief Information Officer sold 4,000 shares at $158.05 ($632,193)
  7. 4 Gift Co-Chief Executive Officer gave 30,000 shares (gift)
  8. 4 Open-market sale Co-Chief Executive Officer sold 37,500 shares at an average $169.16 ($6,343,384)
  9. 4 Option exercise Director acquired 264 shares (option exercise)
  10. 4 Option exercise Director acquired 232 shares (option exercise)
  11. 4 Planned sale Director sold 116 shares at $156.45 ($18,148)
  12. 4 Open-market sale Chief People Officer sold 46,300 shares at an average $165.12 ($7,645,218)
  13. 4 Gift Co-Chief Executive Officer gave 35,000 shares (gift)
  14. 4 Gift Co-Chief Executive Officer gave 75,000 shares (gift)
  15. 4 Gift Chief Legal Officer gave 800 shares (gift)
  16. 4 Open-market sale Chief Commercial Officer sold 63,605 shares at an average $169.58 ($10,786,111)
  17. 4 Open-market sale Director sold 1,700 shares at an average $164.24 ($279,202)
  18. 4 Open-market sale Director sold 14,180 shares at an average $158.92 ($2,253,451)
  19. 4 Option exercise Director acquired 264 shares (option exercise)
  20. 4 Option exercise Director acquired 232 shares (option exercise)

Page 2 of 44 · 876 filings